Ellegaard J, Traunberg H, Dorff B
Scand J Urol Nephrol. 1975;9(2):105-9. doi: 10.3109/00365597509180915.
In 13 out of 26 patients with urinary bladder carcinomas in various stages of malignancy, the ATP-ase activity of circulating lymphocytes was found significantly elevated. A decline in the ATP-ase activity was demonstrated in 14 of 17 patients re-investigated after treatment, while the activity remained unchanged in 2 and rose in 1 patient. No correlation between the clinical tumour stage and the lymphocyte ATP-ase activity was found, but the activity was closely correlated to the histological grade of malignancy. In 11 of the 17 patients the clinical effect of the treatment was closely correlated to a decline in ATP-ase activity. Determination of lymphocyte ATP-ase activity is suggested as an additional and simple help in the diagnosis of bladder carcinoma and in the follow-up control after treatment of patients with this disease.
在26例处于不同恶性阶段的膀胱癌患者中,有13例患者循环淋巴细胞的ATP酶活性显著升高。在17例接受治疗后复查的患者中,14例患者的ATP酶活性下降,2例患者的活性保持不变,1例患者的活性升高。未发现临床肿瘤分期与淋巴细胞ATP酶活性之间存在相关性,但该活性与组织学恶性程度密切相关。17例患者中有11例患者的治疗临床效果与ATP酶活性下降密切相关。建议测定淋巴细胞ATP酶活性,作为膀胱癌诊断及该病患者治疗后随访控制的一项额外的简单辅助手段。